Scarica l'app Stockscreener
0.00
100.00%
-0.695
Lyra Therapeutics Inc Borsa (LYRA) Ultime notizie
LYRA THERAPEUTICS INC by Lyra Therapeutics, Inc. Market Sentiment - Benzinga
LYRA stock rises on Lyra Therapeutics trial and cash data - AD HOC NEWS
Layoff Tracker: EMD Serono may trim R&D workforce by up to 70 - BioSpace
Enterprise value to EBIT forward of Lyra Therapeutics, Inc. – OTC:LYRA - TradingView
Lyra Therapeutics stock trades steadily as sinusitis implant program advances - Ad-hoc-news.de
Price to earnings forward of Lyra Therapeutics, Inc. – OTC:LYRA - TradingView
Enterprise value to EBITDA forward of Lyra Therapeutics, Inc. – OTC:LYRA - TradingView
Enterprise value to revenue forward of Lyra Therapeutics, Inc. – OTC:LYRA - TradingView
Price to sales forward of Lyra Therapeutics, Inc. – OTC:LYRA - TradingView
LYRA stock tracks Lyra Therapeutics after recent filing context. - Ad Hoc News
Lyra Therapeutics, Inc. Actuals & Estimates (OTC:LYRA) - TradingView
Lyra Therapeutics Inc (LYRA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
LYRA Forecast — Price Target — Prediction for 2027 - TradingView
Lyra Therapeutics Inc (LYRA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Lyra Therapeutics Inc (LYRA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Lyra Therapeutics Inc (LYRA) Institutional Confidence - TradingKey
Lyra Therapeutics Inc (LYRA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Lyra Therapeutics Inc (LYRA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Lyra Therapeutics Inc (LYRA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Lyra Therapeutics Inc (LYRA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Lyra Therapeutics Inc (LYRA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Fierce Biotech Layoff Tracker 2026: Genentech trims R&D; Fulcrum shrinks headcount 85% - Fierce Biotech
Lyra Therapeutics, Inc. (LYRA) Reports Q2 Loss, Beats Revenue Estimates - MSN
Lyra Therapeutics (LYRA) director surrenders 640 shares to issuer - Stock Titan
Lyra Therapeutics Inc (OTCM:LYRA) SEC filings - GuruFocus
Lyra Therapeutics Inc (OTCM:LYRA) Stock Price & 30 Year Financial Data - GuruFocus
Lyra Therapeutics Inc (LYRA) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Lyra Therapeutics Inc (OTCM:LYRA) Stock Earnings Transcripts - GuruFocus
Lyra Therapeutics To Conduct One More Trial For Chronic Rhinosinusitis Treatment Candidate - MSN
[15-12G] Lyra Therapeutics, Inc. SEC Filing - Stock Titan
6 biotechs that called it quits in Q1 - BioSpace
Lyra Therapeutics, Inc. Financial Disclosures & SEC Filings - TradingView
Lyra Therapeutics Stock Skyrockets On Positive Trial Data For Its Nasal Implant: Retail’s Thrilled - MSN
Total common shares outstanding of Lyra Therapeutics, Inc. – OTC:LYRA - TradingView
Lyra Therapeutics (NASDAQ: LYRA) files Form 25 to delist from Nasdaq Capital Market - Stock Titan
Lyra Therapeutics, Inc. Announces Intention to Voluntarily File Form 25 for Delisting from Nasdaq and Subsequent Deregistration with the SEC - Sahm
Lyra Therapeutics to delist from Nasdaq, suspend SEC reporting By Investing.com - Investing.com India
Lyra Therapeutics (LYRA) Plans Voluntary Delisting from Nasdaq - GuruFocus
Lyra Therapeutics ends Waltham sublease, agrees to $2.1 million termination payment - Investing.com
Lyra Therapeutics Ends Major Office Sublease Agreement - TipRanks
Lyra Therapeutics (NASDAQ: LYRA) pays $2.1M to exit Waltham lease - Stock Titan
Lyra Therapeutics to delist from Nasdaq, suspend SEC reporting - Investing.com
Lyra Therapeutics, Inc. Announces Intention to Voluntarily - GlobeNewswire
After layoffs, biotech exits 2 Boston-area leases - NBC Boston
After layoffs, Lyra Therapeutics exits Watertown and Waltham leases - The Business Journals
Analyst Upgrade: Is BioRestorative Therapies Inc still a buy after recent gainsInsider Selling & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
Lyra Therapeutics Streamlines Operations with Major Lease Terminations - The Globe and Mail
Lyra Therapeutics to end leases early for Watertown and Waltham facilities By Investing.com - Investing.com South Africa
Lyra Therapeutics, Inc. Files Form 8-K with SEC – Company Details, Stock Info, and Key Disclosures (March 31, 2026) - Minichart
Lyra Therapeutics to end leases early for Watertown and Waltham facilities - Investing.com
Lyra Therapeutics (NASDAQ: LYRA) exits two office leases early - Stock Titan
Biotech layoffs pick back up as 14 companies cut 745 jobs in Q1 - The Business Journals
Lyra Therapeutics (LYRA) CEO returns 2,000 shares to issuer - Stock Titan
Lyra Therapeutics (LYRA) officer returns 667 shares to issuer - Stock Titan
ITRMF Stock Price and Chart — OTC:ITRMF - TradingView
LYRA SEC FilingsLyra Therapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Lyra Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
0.46%
0.84%
Capitalizzazione:
|
Volume (24 ore):